{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:57:53Z","timestamp":1775739473958,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While ankylosing spondylitis (AS) and psoriatic arthritis (PsA) share similar immune dysregulation, their relative risks for inflammatory bowel disease (IBD), including definitive subtypes (Crohn\u2019s disease [CD] and ulcerative colitis [UC]) and possible subtypes (indeterminate colitis [IC] and microscopic colitis [MC]), remain unquantified. We aimed to establish comparative IBD risk gradients among AS, psoriasis (PSO), and PsA cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study utilized a long-term retrospective cohort design by analyzing an electronic health record database. Propensity score matching (PSM) was used to adjust multiple confounders. Cox proportional hazards models and log rank test were employed to evaluate the risk of IBD development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 26,610 patients with AS and 322,317 with PSO (2005\u20132023). After PSM, 26,569 matched pairs were analyzed. Compared to PSO, AS was associated with a significantly higher risk of definite IBD [hazard ratio (HR) = 2.96, 95% CI: 2.64\u20133.33], CD (HR = 3.38, 95% CI: 2.90\u20133.94), UC (HR = 2.43, 95% CI: 2.07\u20132.85), and IC (HR = 2.45, 95% CI: 1.33\u20134.51), but not MC. Subgroup analyses confirmed a consistently higher IBD risk in AS across all ages, sexes, races, BMI categories, and comorbidity profiles. Compared to the general population, AS conferred the highest independent risk for definite IBD (HR = 4.22, 95% CI: 3.60\u20134.94), followed by PsA (HR = 1.52) and PSO (HR = 1.37). AS also showed a 2.60-fold higher definite IBD risk than PsA (95% CI: 2.32\u20132.92).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AS is the phenotype most strongly associated with IBD among the studied spectrum. Compared to PSO, AS confers a significantly higher risk of CD, UC, and IC, and it carries a greater burden of definite IBD than PsA or the general population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1762379","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:48:54Z","timestamp":1770360534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased risk of inflammatory bowel disease in ankylosing spondylitis compared to psoriasis"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhen","family":"He","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Medicine, College of Medicine, Chung Shan Medical University","place":["Taichung, Taiwan"]},{"name":"Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital","place":["Taichung, Taiwan"]},{"name":"Graduate Institute of Integrated Medicine, China Medical University","place":["Taichung, Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Ming","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01282-1","article-title":"More than a leaky gut: how gut priming shapes arthritis","volume":"21","author":"Kuhn","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab617","article-title":"IL-23 and axial disease: do they come together","volume":"60","author":"Mease","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00334-4","article-title":"Role of neutrophil interleukin-23 in spondyloarthropathy spectrum disorders","volume":"5","author":"Macleod","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01218-x","article-title":"Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells","volume":"21","author":"Ohara","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14433","article-title":"The role of IL-23 and the IL-23\/T(H) 17 immune axis in the pathogenesis and treatment of psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.20917","article-title":"Axial spondyloarthritis: A review","volume":"333","author":"Bittar","year":"2025","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","year":"2025","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01097-1","article-title":"The global burden of inflammatory bowel disease: from 2025 to 2045","volume":"22","author":"Kaplan","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.12.025","article-title":"Inflammatory bowel disease-gastroenterology diamond jubilee review","volume":"154","author":"Mahadevan","year":"2018","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz152","article-title":"Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease-A systematic review and meta-analysis","volume":"14","author":"Alinaghi","year":"2020","journal-title":"J Crohns Colitis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212328","article-title":"Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study","volume":"77","author":"Charlton","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"17562848241227037","DOI":"10.1177\/17562848241227037","article-title":"The association between psoriasis, psoriasis severity, and inflammatory bowel disease: a population-based analysis","volume":"17","author":"Shani","year":"2024","journal-title":"Therap Adv Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205253","article-title":"The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.578732","article-title":"Increased risk of inflammatory bowel disease among patients with ankylosing spondylitis: A 13-year population-based cohort study","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13102334","article-title":"Psoriasis as a potential risk factor for inflammatory bowel disease: findings from a nationally representative korean population","volume":"13","author":"Kang","year":"2025","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/bjd.21704","article-title":"Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology","volume":"187","author":"Schneeweiss","year":"2022","journal-title":"Br J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa062","article-title":"Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis","volume":"59","author":"Pittam","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202143","article-title":"Psoriasis, psoriatic arthritis and increased risk of incident Crohn\u2019s disease in US women","volume":"72","author":"Li","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa692","article-title":"Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study","volume":"60","author":"Bengtsson","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001169","article-title":"Prevalence and phenotype of concurrent psoriasis and inflammatory bowel disease","volume":"23","author":"Eppinga","year":"2017","journal-title":"Inflammation Bowel Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf110","article-title":"Incidence of uveitis and inflammatory bowel disease in psoriatic disease, and psoriatic disease in uveitis and inflammatory bowel disease","volume":"64","author":"Williams","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20361","article-title":"Indeterminate colitis: a review of the concept\u2013what\u2019s in a name","volume":"14","author":"Geboes","year":"2008","journal-title":"Inflammation Bowel Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199908000-00018","article-title":"Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali)","volume":"11","author":"Meucci","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2559.2006.02545.x","article-title":"Indeterminate colitis: definition, diagnosis, implications and a plea for nosological sanity","volume":"50","author":"Martland","year":"2007","journal-title":"Histopathology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S268262","article-title":"Indeterminate colitis - update on treatment options","volume":"14","author":"Venkateswaran","year":"2021","journal-title":"J Inflammation Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf140","article-title":"Autoimmune thyroid diseases and microscopic colitis: A nationwide matched case-control study in Sweden","volume":"110","author":"Bergman","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17708","article-title":"Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population-based matched cohort study","volume":"58","author":"Bergman","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S454677","article-title":"Microscopic colitis and risk of incident psoriasis: A nationwide population-based matched cohort study","volume":"16","author":"Bergman","year":"2024","journal-title":"Clin Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16614","article-title":"Autoimmune diseases in microscopic colitis: A Danish nationwide case-control study","volume":"54","author":"Wildt","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e3182802b3e","article-title":"Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort","volume":"19","author":"Lakatos","year":"2013","journal-title":"Inflammation Bowel Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1907607","article-title":"Newer biologic and small-molecule therapies for inflammatory bowel disease","volume":"385","author":"Baumgart","year":"2021","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03159.x","article-title":"Review article: Indeterminate colitis\u2013definition, diagnosis and management","volume":"25","author":"Tremaine","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41572-021-00273-2","article-title":"Microscopic colitis","volume":"7","author":"Burke","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2012.16","article-title":"Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis","volume":"9","author":"Chetty","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.12.026","article-title":"Microscopic colitis: clinical and pathologic perspectives","volume":"13","author":"Munch","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.03.007","article-title":"Microscopic colitis patients demonstrate a mixed Th17\/Tc17 and Th1\/Tc1 mucosal cytokine profile","volume":"55","author":"Kumawat","year":"2013","journal-title":"Mol Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309934","article-title":"Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis","volume":"66","author":"Westerlind","year":"2017","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22838","article-title":"Current and past cigarette smoking significantly increase risk for microscopic colitis","volume":"18","author":"Yen","year":"2012","journal-title":"Inflammation Bowel Dis"},{"key":"B43","article-title":"The epidemiology and risk factors of inflammatory bowel disease","volume":"8","author":"Ye","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e13395","DOI":"10.1111\/sji.13395","article-title":"Effects of smoking on clinical treatment outcomes amongst patients with chronic inflammatory diseases initiating biologics: secondary analyses of the prospective BELIEVE cohort study","volume":"100","author":"Larsen","year":"2024","journal-title":"Scand J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1762379\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:48:55Z","timestamp":1770360535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1762379\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2026.1762379"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1762379","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"article-number":"1762379"}}